MSC-4381

Research use only, not for human use.

MSC-4381 (MCT4-IN-1) is an orally available and selectively modeled highly potent inhibitor of monocarboxylic acid transporter protein 4 (MCT4/SLC16A3) with potential anticancer and antitumor activity for the study of osteosarcoma.

MSC-4381 (MCT4-IN-1) is an orally active and selective monocarboxylate transporter 4 (MCT4/SLC16A3) inhibitor with an IC50 of 77 nM and a Ki of 11 nM. MSC-4381 targets to the cytosolic domain of MCT4. MSC-4381 results in lactate efflux inhibition and reduction of cellular viability in MCT4 high expressing cells. MSC-4381 has the potential for MCT4 transporter inhibition research. MSC-4381 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.

——

Animal Model:MC38 tumor-bearing C57/BL6 miceDosage:30 mg/kg Administration:PO; single dose Result:Only combined with MCT1/2 inhibitor exhibited a significant tumoral intracellular lactate accumulation.Animal Model:Mice Dosage:0.2 mg/kg (Pharmacokinetic Analysis)Administration:IV Result:Had a T1/2 of 1 hours, a CL of 0.33 L/h?kg, a Cmax of 489 ng/mL and a Vss of 0.4 L/kg for mice.

——

Membrane Transporter/Ion Channel

Monocarboxylate Transporter

Monocarboxylate transporter

——

——

2445185-57-7

537.97

C26H20ClN3O6S

>98% (HPLC)

In Vitro:?DMSO : 83.33 mg/mL (154.90 mM; Ultrasonic (<60°C)

CCOc1ccc(c2ncccc12)S(=O)(=O)Nc1ccc(Cl)cc1C#Cc1cnc(cc1OC)C(O)=O

——

(-20℃)

With Ice Pack

≥ 2 years